Yutaka Kawakami

Affiliations: 
Keio University, Minato-ku, Tōkyō-to, Japan 
Google:
"Yutaka Kawakami"
Mean distance: 16.96 (cluster 17)
 

Children

Sign in to add trainee
Yohei Ohashi research assistant 2000-2004 Keio University
Yukihiko Iizuka grad student 1999-2004 Keio University
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hirai I, Funakoshi T, Kamijuku H, et al. (2021) Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Science
Kinoshita T, Sayem MA, Yaguchi T, et al. (2021) Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors. Cancer Science
Nakamura K, Okuyama R, Kawakami Y. (2020) Renin-Angiotensin System in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1277: 105-114
Sugihara E, Hashimoto N, Osuka S, et al. (2020) The inhibitor of apoptosis protein Livin confers resistance to Fas-mediated immune cytotoxicity in refractory lymphoma. Cancer Research
Yamane M, Sato S, Shimizu E, et al. (2020) Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Tamura R, Fujioka M, Morimoto Y, et al. (2020) Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 11: 2028
Tamura R, Morimoto Y, Kosugi K, et al. (2020) Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 301
Tamura R, Morimoto Y, Kosugi K, et al. (2020) Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 196
Kawakami Y, Ohta S, Sayem MA, et al. (2020) Immune-resistant mechanisms in cancer immunotherapy. International Journal of Clinical Oncology
Tamura R, Fujioka M, Morimoto Y, et al. (2019) A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 10: 5758
See more...